New Ni(II) and UO2(II) metallomesogens obtained from mesomorphic N,N′‐salicyliden(3,3′‐diamine‐N‐methyldipropylamine) ligands containing a pentadentate N3O2 chelating cavity and bearing two or four lateral substituents, are isolated and fully characterized. Some of the synthesized nickel and dioxouranium complexes show a SmC mesophase. To the best of our knowledge, these species are the first pentacoordinated Ni(II) and heptacoordinated UO2(II) metallomesogens to be reported.
No takes yet. Share an insight, caveat, or question.
Aiello et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: